Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.04
11% from low
Exchange
OTC Link
CS
Borrow rate
0.27%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.1M | $15.6M | $9.6M | $7.8M | $6.0M | $5.8M | $5.1M | $0 |
| Cost of revenue | $10.5M | $12.7M | $4.0M | $1.6M | $2.3M | $1.6M | $1.2M | $0 |
| Gross profit | $3.6M | $2.9M | $5.5M | $6.2M | $3.7M | $4.2M | $3.9M | $0 |
| Gross margin | 25.4% | 18.4% | 57.7% | 79.5% | 61.8% | 72.0% | 76.3% | — |
| R&D | $0 | $0 | $459.6K | $1.8M | $1.7M | $2.4M | $2.6M | $0 |
| Operating income | −$7.7M | −$19.3M | −$17.3M | −$18.0M | −$19.9M | −$13.6M | −$17.7M | −$4.6M |
| EBITDA | $373.6K | −$14.0M | −$12.2M | −$1.7M | −$13.7M | −$4.2M | −$10.8M | −$4.5M |
| Net income | −$32.5M | −$32.5M | −$20.6M | −$9.0M | −$20.0M | −$8.2M | −$14.3M | $1.9M |
| Net margin | -231.1% | -208.7% | -215.3% | -115.0% | -334.4% | -140.2% | -280.1% | — |
| EPS (diluted) | -324.73 | -132.16 | -38.55 | -8.25 | -9.68 | -6.35 | -3.34 | -1.56 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $11M | $-27.50 | $-27.50–$-27.50 | 1 |
| 2027 | $21M | $-17.50 | $-17.50–$-17.50 | 1 |
| 2028 | $28M | $0.34 | $0.34–$0.34 | 1 |
Forward consensus · source: Financial Modeling Prep
PETROS PHARM INC
No one on the platform currently holds PTPI.
No tracked institution reports a position in PTPI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-05-01 | 1-for-25reverse |
| 2022-12-01 | 1-for-10reverse |
No one on the platform has traded PTPI yet.
| $3M |
| — |
| LIXTLixte Biotechnology Holdings, Inc. | $8.04 | +11.82% | $99M | — |
| PETVPetVivo Holdings, Inc. | $0.88 | +3.53% | $24M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.0× sales vs its 54.2× historical median P/S.
Fair value ≈ $27.31 · price $0.01 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$PTPI Market Cap Market Cap 317,792 04/22/2026 Authorized Shares 7,000,000,000 04/22/2026 Outstanding Shares 42,372,260 04/22/2026 Restricted 121,925 04/22/2026 Unrestricted 42,250,335 04/22/2026 Held at DTC 42,237,840 04/22/2026 Float 42,249,113 05/28/2025 The positive news is no added shares!
View on StockTwits ↗$PTPI no real danger ahead as long as they do not start diluting. rare find 👌if you have the stomach to hold hodl
View on StockTwits ↗$PTPI @Rainbow_DooDoo 👀 sell me those shares baby!
View on StockTwits ↗$PTPI https://x.com/valyeai/status/2045321643015426363?s=46 seems to be picking up attention. gonna purchase a few thousand shares tomorrow. this could easily go to $1
View on StockTwits ↗$PTPI Jane Street probably shorting shares of PTPI last May when the stock took a huge nosedive . They bought $39,000 of shares as a hedge to shorting the stock. They made way more shorting the stock. They’re an “Authorized Participant.” They don’t have to report short positions, options or derivatives like a Hedge Fund or a Bank. Jane Street is a “Quantitative Trading Firm” Watch “How Wall Street Took Over Bitcoin” (Andrei Jikh) on YouTube.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.